Lido Advisors
QNRX

Lido Advisors’s Quoin Pharmaceuticals QNRX Stock Holding History

Lido Advisors’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-672
Closed -$5.26K – 1735
2025
Q1 		$5.26K Buy
+672
New +$8.84K ﹤0.01% 1503

Other funds holding QNRX

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lido Advisors's QNRX Position: Q2 2025 in Review

Lido Advisors sold out of Quoin Pharmaceuticals (QNRX) in Q2 2025, closing a stake of 672 shares — an estimated $5.26K sold.

Lido Advisors first reported a position in QNRX in Q1 2025 and held it in 1 quarter. The position peaked at $5.26K in Q1 2025. 7 funds tracked by Wall St. Rank hold QNRX as of Q2 2025.

  • Lido Advisors reported no remaining Quoin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Lido Advisors sold 672 Quoin Pharmaceuticals shares in Q2 2025, an estimated $5.26K.
  • Lido Advisors first reported a position in Quoin Pharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Lido Advisors's Quoin Pharmaceuticals position peaked at $5.26K in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2025.

Based on Lido Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.